NCT04405167 2025-10-07Tasquinimod for the Treatment of Relapsed or Refractory MyelomaUniversity of PennsylvaniaPhase 1 Terminated30 enrolled
NCT01887587 2020-01-22Vincristine, Doxorubicin, And Dexamethasone + Ixazomib in Acute Lymphoblastic Leukemia (ALL), Lymphoblastic Lymphoma Or Mixed Phenotype Acute LeukemiaMedical College of WisconsinPhase 1 Terminated5 enrolled 9 charts